Clinical trial on the QOL of the Tegafur/Uracil plus Leucovolin(UFT/LV) to adjuvant chemotherapy for the Stage II, III colorectal cancer

ABSTRACT: Interventions: Tegafur/uracil with oral leucovorin(UFT/LV) UFT is administered orally at 300mg/m2/day with 75mg/day of oral leucovorin for 21 consecutive days followed by a 7 days rest. Primary outcome(s): Quality of Life Study Design: Single arm Non-randomized

DISEASE(S): Resectable Stageii, Iii Colorectal Cancer

PROVIDER: 2624363 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR